Literature DB >> 17174036

Pathways between ecstasy initiation and other drug use.

Silvia S Martins1, Lilian A Ghandour, Howard D Chilcoat.   

Abstract

This study aims to shed light on drug use pathways associated with ecstasy use initiation. Data from 54,573 respondents aged 12-21 years old from the 2002-2003 National Survey on Drug Use and Health (NSDUH) public use data files were analyzed via Cox proportional hazards models with time-dependent covariates. Our findings showed that marijuana, cocaine, and heroin were significant independent predictors of subsequent ecstasy use. Earlier ecstasy initiation was significantly associated with subsequent other illegal drug initiation (marijuana, cocaine and heroin). The strength of the association was greater for the pathway from earlier marijuana initiation to subsequent ecstasy initiation as compared to the pathway in the opposite direction. The pathway from earlier ecstasy initiation to subsequent cocaine and heroin initiation was also stronger as compared to pathways in the opposite directions. Pathways between ecstasy initiation and marijuana, cocaine and heroin initiation seem to be independent of the association between drug use and psychiatric symptoms/deviant behaviors. Ecstasy initiation seems to play a role in the subsequent initiation of cocaine and heroin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174036      PMCID: PMC1904509          DOI: 10.1016/j.addbeh.2006.11.003

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  8 in total

1.  Does marijuana use cause the use of other drugs?

Authors:  Denise B Kandel
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

2.  Trends in ecstasy use in the United States from 1995 to 2001: comparison with marijuana users and association with other drug use.

Authors:  Silvia S Martins; Guido Mazzotti; Howard D Chilcoat
Journal:  Exp Clin Psychopharmacol       Date:  2005-08       Impact factor: 3.157

3.  Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.

Authors:  Petra Zimmermann; Hans-Ulrich Wittchen; Florian Waszak; Agnes Nocon; Michael Höfler; Roselind Lieb
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

4.  Recent-onset ecstasy use: association with deviant behaviors and psychiatric comorbidity.

Authors:  Silvia S Martins; Guido Mazzotti; Howard D Chilcoat
Journal:  Exp Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.157

5.  Mental disorders in ecstasy users: a prospective-longitudinal investigation.

Authors:  Roselind Lieb; Christian G Schuetz; Hildegard Pfister; Kirsten von Sydow; Hans Wittchen
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

Review 6.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

7.  Escalation of drug use in early-onset cannabis users vs co-twin controls.

Authors:  Michael T Lynskey; Andrew C Heath; Kathleen K Bucholz; Wendy S Slutske; Pamela A F Madden; Elliot C Nelson; Dixie J Statham; Nicholas G Martin
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

8.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

  8 in total
  12 in total

1.  Ecstasy use and suicidal behavior among adolescents: findings from a national survey.

Authors:  Jueun Kim; Bin Fan; Xinhua Liu; Nancy Kerner; Ping Wu
Journal:  Suicide Life Threat Behav       Date:  2011-06-01

2.  Correlates of African American female adolescent offenders 3, 4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") use and sexually transmitted infection morbidity.

Authors:  Torrance Stephens; Rhonda Conerly Holliday; Shakita Hopkins; Shanhol Rose; Ronald Braithwaite; Selina Smith
Journal:  J Hum Behav Soc Environ       Date:  2015-09-29

3.  Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?

Authors:  Silvia S Martins; Carla L Storr; Pierre K Alexandre; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2007-12-18       Impact factor: 4.492

4.  Ecstasy use among US adolescents from 1999 to 2008.

Authors:  Ping Wu; Xinhua Liu; Trang Hoang Pham; Jue Jin; Bin Fan; Zhezhen Jin
Journal:  Drug Alcohol Depend       Date:  2010-06-08       Impact factor: 4.492

5.  3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth.

Authors:  Stephanie Lake; Andrew Gaddis; Kenneth W Tupper; Ekaterina Nosova; Kora DeBeck
Journal:  Subst Abus       Date:  2018-11-20       Impact factor: 3.716

6.  Factors associated with initiation of ecstasy use among US adolescents: findings from a national survey.

Authors:  Ping Wu; Xinhua Liu; Bin Fan
Journal:  Drug Alcohol Depend       Date:  2009-09-24       Impact factor: 4.492

7.  Self-reported ecstasy (MDMA) use and past occurrence of sexually transmitted infections (STIs) in a cohort juvenile detainees in the USA.

Authors:  Torrance Stephens; Rhonda Conerly Holliday; Jerriyauna Jarboe
Journal:  J Community Health       Date:  2015-04

8.  Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Roger D Weiss; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2009-06-04       Impact factor: 4.492

9.  The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys.

Authors:  Silvia S Martins; Pierre K Alexandre
Journal:  Addict Behav       Date:  2008-08-03       Impact factor: 3.913

10.  Decision making as a predictor of first ecstasy use: a prospective study.

Authors:  Thelma Schilt; Anneke E Goudriaan; Maarten W Koeter; Wim van den Brink; Ben Schmand
Journal:  Psychopharmacology (Berl)       Date:  2008-11-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.